Daewoong's botulinum toxin Nabota enters Kuwait
- Source
- The Korea Herald - Business
- Source link
- https://www.koreaherald.com/article/10825771
- Published
- 2026-07-30 13:50:15
- Discovered by ProcIntel
- 2026-07-31 10:43:27
- Category
- Procurement & Supply Chain News
- Geography
- South Korea
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Daewoong Pharmaceutical's botulinum toxin brand Nabota has entered Kuwait, expanding its presence to seven Middle Eastern markets while setting a record among Korean botulinum toxin makers in the region. According to Daewoong Pharmaceutical on Thursday, it began supplying Nabota to Kuwait earlier this month on top of its existing market lineup of Saudi Arabia, the United Arab Emirates, Turkiye, Qatar, Egypt and Bahrain in the Middle East. With the latest expansion, Daewoong underscored that Nabo
Procurement Relevance Gate
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.